GO:0006386 termination of RNA polymerase III transcription: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006386 describes the process by which RNA polymerase III (Pol III) stops transcription, a termination event that is intrinsic to the enzyme and triggered by at least four contiguous uridine residues in the nascent RNA.
• Pol III termination is coupled to RNA release and polymerase recycling, and recent integrated models propose that multiple factors cooperate to ensure efficient termination in vivo.
• Structural studies have revealed how Pol III recognizes poly-deoxythymidine tracts and traps the termination signal, providing a mechanistic basis for the U4 rule.
• Termination of Pol III transcription is essential for producing tRNAs, 5S rRNA, and other small RNAs, and its dysregulation is linked to cancer and other diseases.
• Emerging evidence shows that Pol III can be recruited to protein-coding gene promoters, suggesting broader roles for Pol III termination in gene regulation.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of termination factors and their physiological relevance.
Description
Termination of RNA polymerase III transcription (GO:0006386) is the biological process that completes the synthesis of a primary RNA polymerase III transcript. Unlike RNA polymerase II, which relies on polyadenylation signals and multiple termination factors, RNA polymerase III has an intrinsic ability to terminate transcription upon incorporation of at least four contiguous uridine residues into the nascent RNA. This mechanism ensures the precise end formation of short, abundant non-coding RNAs such as tRNAs, 5S rRNA, and U6 snRNA, which are essential for translation and RNA processing. Understanding this process is critical because it controls the output of the Pol III transcriptome, and its misregulation has been implicated in human diseases including cancer and neurodegeneration. Recent structural and biochemical studies have provided detailed insights into how Pol III recognizes termination signals and how accessory factors modulate this process. Moreover, evidence of Pol III recruitment and transcription at protein-coding gene promoters suggests that Pol III termination may have broader regulatory roles beyond classical non-coding RNA genes. Researchers studying gene expression, RNA biology, and disease mechanisms therefore require robust experimental models to interrogate the factors and regulatory layers controlling Pol III termination.
termination of RNA polymerase III transcription At A Glance
| GO ID | GO:0006386 |
|---|---|
| GO term | termination of RNA polymerase III transcription |
| Ontology | biological_process |
| Synonym | RNA polymerase III transcription termination; RNA polymerase III transcription termination factor activity; transcription termination from Pol III promoter; transcription termination from RNA polymerase III promoter |
| Major function | Intrinsic termination of Pol III transcription via poly-U tracts, leading to release of short non-coding RNAs |
| Definition | A transcription termination process that completes the production of a primary RNA polymerase III transcript; Pol III terminates upon incorporation of at least 4 contiguous U residues |
| Related processes | tRNA processing, 5S rRNA synthesis, U6 snRNA biogenesis, RNA polymerase III recycling |
| Key structural feature | Poly-deoxythymidine (poly-dT) tract in the template DNA and poly-U in the RNA |
| Regulatory layers | Accessory factors, chromatin state, and nutrient signaling influence Pol III termination efficiency |
What Is GO:0006386?
According to the Gene Ontology, GO:0006386 is defined as a transcription termination process that completes the production of a primary RNA polymerase III transcript. RNA polymerase III has an intrinsic ability to terminate transcription upon incorporation of at least 4 contiguous U residues. This definition captures the core biochemical feature: termination is signaled by a run of uridines in the RNA, which causes the polymerase to pause and release the transcript without the need for additional cleavage and polyadenylation factors.
Why Is termination of RNA polymerase III transcription Important in Cell Biology?
Termination of RNA polymerase III transcription is a fundamental step in the biogenesis of small non-coding RNAs that are required for protein synthesis and RNA processing. Because Pol III produces tRNAs, 5S rRNA, and other essential RNAs, defects in termination can alter the cellular pool of these molecules and impact translation, cell growth, and stress responses. Moreover, Pol III termination is emerging as a regulatory hub: recent work shows that Pol III can be recruited to protein-coding gene promoters, suggesting that termination events may influence gene expression more broadly. Understanding the molecular details of termination, including the role of poly-U tracts and accessory factors, is therefore essential for dissecting normal physiology and disease mechanisms.
• Ensures correct 3' end formation of tRNAs, 5S rRNA, and other Pol III transcripts, which are essential for translation and RNA processing.
• Dysregulation of Pol III transcription and termination has been linked to cancer, where increased tRNA output supports proliferation.
• Pol III termination factors are potential therapeutic targets because they control the availability of tRNAs and other small RNAs.
• Structural insights into Pol III termination provide a framework for understanding how mutations in termination signals affect RNA output.
• Emerging evidence implicates Pol III in transcription at protein-coding gene promoters, expanding the functional repertoire of Pol III termination.
• CRISPR-based editing of termination signals or factors enables causal testing of their roles in cell models.
• Termination efficiency influences Pol III recycling and the overall rate of tRNA synthesis, impacting cell growth under stress.
• Studying Pol III termination helps explain how cells balance tRNA supply with demand during development and disease.
What Happens During termination of RNA polymerase III transcription?
Recognition of the poly-U termination signal
In simple terms: The polymerase reads a stretch of DNA that codes for several U's in the RNA, and this acts like a stop sign.
During elongation, RNA polymerase III synthesizes RNA until it encounters a template DNA sequence that encodes at least four contiguous uridines in the nascent transcript. This poly-U signal is recognized by the polymerase, which pauses and becomes competent for termination. Structural studies have shown that Pol III traps poly-deoxythymidine tracts, stabilizing the paused state and facilitating subsequent steps.
Pausing and conformational changes
In simple terms: The polymerase slows down and changes shape, which helps it let go of the RNA and DNA.
Upon encountering the poly-U signal, Pol III undergoes conformational changes that lead to a paused elongation complex. This paused state is a prerequisite for efficient termination and involves interactions between the polymerase and the RNA-DNA hybrid. The intrinsic ability of Pol III to terminate is thus tightly coupled to its structural dynamics during elongation.
RNA release and polymerase recycling
In simple terms: The newly made RNA is released, and the polymerase is freed to start again.
Following pausing, the RNA transcript is released from the polymerase, and the enzyme dissociates from the DNA template. This step completes the termination process and allows Pol III to be recycled for subsequent rounds of transcription. Recent integrated models propose that additional factors may assist in RNA release and polymerase recycling in vivo, ensuring efficient termination under varying cellular conditions.
Coupling to RNA processing and quality control
In simple terms: After termination, the RNA is checked and processed so it can do its job.
Terminated Pol III transcripts often undergo processing, such as 5' leader removal and 3' trailer trimming for tRNAs. Termination efficiency can influence the fate of these RNAs, and quality control pathways may degrade improperly terminated transcripts. This coupling ensures that only correctly terminated RNAs enter the functional pool.
Regulation by accessory factors and chromatin
In simple terms: Other proteins and the way DNA is packaged can speed up or slow down the stop sign.
Although Pol III termination is intrinsic, accessory factors and chromatin context can modulate its efficiency. For example, the La protein and other RNA-binding proteins influence termination and recycling. Additionally, novel layers of Pol III control, including post-translational modifications and chromatin remodeling, affect tRNA gene transcription and termination.
Key Genes Involved in GO:0006386 termination of RNA polymerase III transcription
The following genes and proteins are central to the termination of RNA polymerase III transcription, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POLR3A | Catalytic subunit of RNA polymerase III | Mutations affect termination and are linked to leukodystrophy |
| POLR3B | Second largest subunit of Pol III | Structural and functional studies of termination |
| POLR3C | Subunit of Pol III | Involved in polymerase assembly and termination |
| POLR3D | Subunit of Pol III | Contributes to termination efficiency |
| POLR3E | Subunit of Pol III | Required for intrinsic termination |
| POLR3F | Subunit of Pol III | Part of the polymerase core |
| POLR3G | Subunit of Pol III | Regulates Pol III activity and termination |
| POLR3H | Subunit of Pol III | Involved in termination and recycling |
| POLR3K | Subunit of Pol III | Essential for termination |
| POLR2A | Subunit of RNA polymerase II | Used as a comparison for termination mechanisms |
| La protein (SSB) | RNA-binding protein | Binds Pol III transcripts and influences termination |
| Maf1 | Repressor of Pol III transcription | Regulates Pol III output and termination |
| TFIIIC | Transcription factor | Recruits Pol III to tRNA genes |
| TFIIIB | Transcription factor | Required for initiation and influences termination |
| TBP | TATA-binding protein | Part of TFIIIB complex |
| BRF1 | Subunit of TFIIIB | Essential for Pol III recruitment |
| BDP1 | Subunit of TFIIIB | Involved in Pol III transcription |
How Is termination of RNA polymerase III transcription Regulated?
Termination of RNA polymerase III transcription is primarily intrinsic, but its efficiency can be modulated by accessory factors and cellular signaling. The La protein binds to the 3' ends of Pol III transcripts and influences termination and recycling. Maf1 is a key repressor of Pol III transcription that responds to nutrient availability and stress, thereby indirectly affecting termination rates. Additionally, chromatin state and post-translational modifications of Pol III subunits contribute to the regulation of termination in vivo. Emerging evidence suggests that Pol III recruitment to protein-coding gene promoters may also be subject to regulatory inputs, expanding the scope of Pol III termination control.
termination of RNA polymerase III transcription and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POLR3A | Hypomyelinating leukodystrophy | Knockout or point-mutation in cell lines |
| POLR3B | Leukodystrophy | Knock-in of patient mutations |
| Maf1 | Cancer and metabolic stress | Overexpression or knockout |
| La protein (SSB) | Autoimmune disease and cancer | Knockdown or knockout |
| BRF1 | Cancer | Overexpression and knockout |
Cancer
Dysregulation of RNA polymerase III transcription, including termination, is frequently observed in cancer. Increased Pol III output supports the elevated protein synthesis demands of cancer cells, and components of the Pol III machinery are often overexpressed or hyperactivated. Targeting Pol III termination factors may therefore offer therapeutic opportunities.
Neurodegeneration and leukodystrophy
Mutations in POLR3A and POLR3B, which encode subunits of Pol III, cause hypomyelinating leukodystrophies. These mutations can affect transcription and termination, leading to impaired tRNA synthesis and neuronal dysfunction.
Ribosomopathies and translational stress
Defects in Pol III termination can alter the pool of tRNAs and 5S rRNA, impacting ribosome assembly and translation. This can contribute to ribosomopathies and cellular stress responses.
From termination of RNA polymerase III transcription-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a termination factor affect tRNA levels? | Knockout cell lines |
| How do point mutations in Pol III subunits affect termination? | Point-mutation knock-in |
| Can a tagged termination factor be used to study localization? | Tagged knock-in |
| Does overexpression of Maf1 alter Pol III termination? | Overexpression |
| What is the effect of a termination signal mutation on RNA output? | CRISPR-edited poly-U tract |
| Can CRISPR screening identify novel termination regulators? | Library screening |
How to Study the termination of RNA polymerase III transcription Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state RNA levels | Detect termination read-through |
| Small RNA-seq | tRNA and small RNA abundance | Quantify Pol III transcript output |
| Cryo-EM | 3D structure of Pol III complexes | Visualize termination intermediates |
| In vitro transcription | Termination efficiency | Test poly-U signal strength |
| CRISPR screen | Gene function at scale | Identify novel termination regulators |
| ChIP-seq | Pol III occupancy | Map Pol III binding sites |
| Proteomics | Protein interactions | Find termination accessory factors |
RNA sequencing and small RNA profiling
RNA-seq and small RNA-seq can quantify Pol III transcripts and detect termination defects. Changes in tRNA and 5S rRNA levels or the appearance of read-through transcripts indicate altered termination.
Structural biology (cryo-EM and X-ray crystallography)
Structural studies of Pol III elongation complexes have revealed how poly-U signals are recognized and how the polymerase undergoes conformational changes during termination.
Biochemical termination assays
In vitro transcription assays using purified Pol III and template DNA with poly-U tracts allow direct measurement of termination efficiency and the effects of accessory factors.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate Pol III termination and tRNA output, linking genotype to phenotype.
How CRISPR Can Be Used to Study GO:0006386 termination of RNA polymerase III transcription
Knockout
CRISPR knockout of Pol III subunits or termination factors can reveal their essentiality and impact on tRNA and 5S rRNA production. For example, knocking out Maf1 leads to increased Pol III transcription and altered termination dynamics.
Point Mutation
Introducing point mutations in the poly-U tract or in Pol III subunits via CRISPR prime editing allows precise testing of termination signals and structural determinants.
Knock-in
Knock-in of tagged versions of Pol III subunits or accessory factors enables localization and interaction studies, providing insights into termination complex dynamics.
Overexpression
Overexpression of termination factors such as La protein or Maf1 can be achieved by CRISPR activation or cDNA delivery, allowing gain-of-function studies on Pol III termination.
How EDITGENE Supports termination of RNA polymerase III transcription Research
Researchers studying termination of RNA polymerase III transcription-related genes often need to determine whether a candidate gene is causally involved in termination efficiency, tRNA output, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations.
Contact EDITGENE today to design your custom CRISPR model for termination of RNA polymerase III transcription research.
Frequently Asked Questions About termination of RNA polymerase III transcription
What is termination of RNA polymerase III transcription?
It is the process by which RNA polymerase III stops transcription, typically upon encountering a poly-U signal in the nascent RNA, completing the synthesis of small non-coding RNAs.
What genes are involved in termination of RNA polymerase III transcription?
Key genes include POLR3A, POLR3B, POLR3C, POLR3D, POLR3E, POLR3F, POLR3G, POLR3H, POLR3K, as well as accessory factors like La protein and Maf1.
How does RNA polymerase III know when to stop?
It recognizes a template DNA sequence that encodes at least four contiguous uridines in the RNA, which causes the polymerase to pause and release the transcript.
What is the role of poly-U in Pol III termination?
The poly-U tract in the RNA is the intrinsic termination signal; at least four U residues are required for efficient termination.
Which diseases are linked to defects in Pol III termination?
Mutations in Pol III subunits are linked to leukodystrophy, and dysregulated Pol III transcription is observed in cancer.
How can CRISPR be used to study Pol III termination?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of termination factors and signals to test their function.
What methods are used to measure Pol III termination?
RNA-seq, small RNA-seq, in vitro transcription assays, and structural biology are commonly used.
Is Pol III termination regulated?
Yes, accessory factors such as La protein and Maf1, as well as chromatin state, can modulate termination efficiency.
What is the difference between Pol II and Pol III termination?
Pol II termination requires polyadenylation signals and multiple factors, whereas Pol III termination is intrinsic and depends on poly-U tracts.
Can Pol III terminate at protein-coding genes?
Recent evidence shows that Pol III can be recruited to protein-coding gene promoters, suggesting broader roles for Pol III termination.
Conclusion
Termination of RNA polymerase III transcription (GO:0006386) is a precisely regulated process that ensures the correct 3' end formation of essential non-coding RNAs. Its intrinsic mechanism, driven by poly-U signals, is complemented by accessory factors and regulatory inputs that fine-tune Pol III output. Dysregulation of this process is linked to cancer and neurological disorders, making it a compelling area of research. Advances in CRISPR-based models and structural biology continue to illuminate the molecular details of Pol III termination, offering new opportunities for therapeutic intervention.
References
- 2. K C R et al.. 2024. Evidence of RNA polymerase III recruitment and transcription at protein-coding gene promoters.. Mol Cell 84(21):4111-4124.e5 PMID: 39393362
- 3. Yan J et al.. 2024. Improving prime editing with an endogenous small RNA-binding protein.. Nature 628(8008):639-647 PMID: 38570691
- 4. Girbig M et al.. 2022. Structural insights into nuclear transcription by eukaryotic DNA-dependent RNA polymerases.. Nat Rev Mol Cell Biol 23(9):603-622 PMID: 35505252
- 5. Xie J et al.. 2022. An integrated model for termination of RNA polymerase III transcription.. Sci Adv 8(28):eabm9875 PMID: 35857496
- 6. Hou H et al.. 2021. Structural insights into RNA polymerase III-mediated transcription termination through trapping poly-deoxythymidine.. Nat Commun 12(1):6135 PMID: 34675218
- 7. Arimbasseri AG et al.. 2013. Transcription termination by the eukaryotic RNA polymerase III.. Biochim Biophys Acta 1829(3-4):318-30 PMID: 23099421
- 8. Leśniewska E et al.. 2017. Novel layers of RNA polymerase III control affecting tRNA gene transcription in eukaryotes.. Open Biol 7(2) PMID: 28228471
